Primary market enthusiasm has turned more selective after the strong rally seen in earlier listings. Market experts noted that investors are now differentiating sharply between high-quality and average offerings.
Primary market enthusiasm has turned more selective after the strong rally seen in earlier listings. Market experts noted that investors are now differentiating sharply between high-quality and average offerings.
Healthcare and diagnostics companies are drawing growing investor interest in the primary market. Recent filings indicate multiple firms from fertility, diagnostics and hospital segments are evaluating IPO plans.
India’s capital markets are poised for another strong year of public offerings, with investment banks projecting robust fund-raising momentum. The country witnessed more than 100 companies raising roughly $22 billion last year, highlighting sustained investor participation.
India’s primary market continues to witness steady activity even after a relatively slow start to the year. Experts indicate that investor appetite remains healthy, supported by strong domestic liquidity and sustained retail participation.
Mumbai-based analytics firm Fractal Analytics has scaled down the size of its upcoming public issue by more than 40%, signalling a cautious approach amid mixed primary market sentiment. The revised IPO is now pegged at about $314 million, making it one of India’s first pure-play AI listings.
Incorporated in 2021, Striders Impex Ltd. (SIL) is engaged in licensing, own brand development and distribution of toys and kids’ consumer merchandise. It provides end-to-end solutions spanning product design, sourcing, manufacturing and distribution, catering to multiple retail formats across India and select global markets. SIL is strategically investing in building its direct-to-consumer presence through e-commerce […]
Fractal Analytics made a weak stock market debut, with shares falling about 5% below the issue price on listing. The company’s IPO had been fully subscribed but saw cautious investor participation toward the close.
Dairy major Milky Mist is moving ahead with its planned IPO in 2026 even as broader market volatility persists. The firm had earlier secured regulatory approval for the public issue and aims to complete the listing within the validity period.
The Rs. 165 cr. IPO of Gaudium IVF & Women Health is witnessing encouraging investor interest during the ongoing bidding process. Grey market data shows the shares trading at around an 11% premium over the issue price.
Kiaasa Retail has opened its Rs. 70 cr. SME IPO for subscription, with the issue closing on 25th February 2026. The price band has been fixed at Rs. 121–127 per share.
For those of you who are serious about having more, doing more, giving more and being more, success is achievable with some understanding of what to do.
